Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06503354 · ClinicalTrials.gov registry record
Gait Metric Validation of the Cionic Neural Sleeve
A clinical trial, sponsored by Cionic.
- Completed
- Registry status
- 29
- Enrollment target
NCT06503354: Completed study, sponsored by Cionic.
NCT06503354 is a clinical trial that has completed, run by Cionic. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06503354 has completed, sponsored by Cionic.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the validity of the Neural Sleeve gait metrics compared to gait parameters assessed with a Protokinetics Zeno pressure sensitive walkway. The spatiotemporal gait parameters obtained from the Zeno walkway have been rigorously validated and will represent the "gold standard" ground truth measurements in the proposed protocol. Confirming the validity of the Neural Sleeve metrics offers benefit to individuals who utilize the device by providing confidence that calculated gait reports are accurate and can be used to inform usage of the device and associated gait changes over time. Findings of inaccuracy would still offer benefit in the form of knowing that the Neural Sleeve metrics need to be used with caution and/or updated to provide correct outcomes to users.
Primary Outcome
Time one takes to walk a specified distance (expressed as a ratio between distance and time, in centimeters per second)
Interventions
- DEVICE Neural Sleeve and Zeno walkway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2025-12-11 |
What the finished NCT06503354 record still lists
NCT06503354 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neural Sleeve and Zeno walkway is the first listed.
NCT06503354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06503354 about?
NCT06503354 is a clinical study titled "Gait Metric Validation of the Cionic Neural Sleeve". The purpose of this study is to determine the validity of the Neural Sleeve gait metrics compared to gait parameters assessed with a Protokinetics Zeno pressure sensitive walkway. The spatiotemporal gait parameters obtained from the Zeno walkway have been rigorously validated and will represent the ...
What is the current status of trial NCT06503354?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2024-07-08. Estimated completion is 2025-12-11.
What interventions are being tested in trial NCT06503354?
The interventions under investigation include: Neural Sleeve and Zeno walkway (DEVICE).
Who is sponsoring clinical trial NCT06503354?
This trial is sponsored by Cionic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI